Merlin team meet in Padua

The Merlin partners met in Padua on 22 and 23 January for our most recent plenary. The team heard updates from workstreams across the project and discussed the reports to be submitted to the EU by the end of January. MSC manufacture and plans for the clinical trial were also a key focus. An exploitation workshop was held where future exploitation plans were considered. Many thanks to UNIPD for hosting such a successful meeting in such a wonderful location!

 

S. de Witte, Erasmus MC presents MERLIN findings in 2017

S. de Witte of Erasmus University Medical Center in Rotterdam took to the road in 2017 to present MERLIN results at five conferences in Belgium, The Netherlands and Spain:

· Erasmus MC, Science days of the Department of Internal Medicine, Antwerp
Poster: IMPACT OF CULTURE EXPANSION AND INFLAMMATORY CYTOKINE CHALLENGE ON DNA METHYLATION PROFILES IN MSC

· BOOT conference, Dutch Transplantation Society, Groningen
Presentation 1: Ageing of bone marrow and umbilical cord-derived MSC during culture expansion
Presentation 2: In vivo tracking of live and dead mesenchymal stromal cells

· MOLMED day, Erasmus MC molecular medicine, Rotterdam
Poster: IMPACT OF CULTURE EXPANSION AND INFLAMMATORY CYTOKINE CHALLENGE ON DNA METHYLATION PROFILES IN MSC

· European Society for Organ Transplantation (ESOT), Barcelona
Presentation 1: Impact of culture expansion and inflammatory cytokine challenge on DNA methylation profiles in MSC
Presentation 2: Tracking and fate of umbilical cord-derived MSC after intravenous infusion in mice (presented by F. Luk)

· European Hematology Association (EHA), EHA-SWG Scientific Meeting on Shaping the Future of Mesenchymal Stromal Cells Therapy, Amsterdam
Presentation: Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells

After six conference talks and poster presentations, she remarked, ”It was nice to connect with the experts in the field”.